Newly-developed vitiligo following COVID-19 mRNA vaccine.

Ugurer, Ece; Sivaz, Onur; Kivanç Altunay, Ilknur

Ugurer, Ece; Sivaz, Onur; Kivanç Altunay, Ilknur.

Ugurer E; Department of Dermatology, Lüleburgaz State Hospital, Kirklareli, Turkey.
Sivaz O; Department of Dermatology, Health Sciences University, Sisli Hamidiye Etfal Research and Training Hospital, Istanbul, Turkey.
Kivanç Altunay I; Department of Dermatology, Health Sciences University, Sisli Hamidiye Etfal Research and Training Hospital, Istanbul, Turkey.

J Cosmet Dermatol ; 21(4): 1350-1351, 2022 04.

Article in English | MEDLINE | ID: covidwho-1685367

Subject(s)

COVID-19; Hypopigmentation; Vitiligo; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Humans; Vaccines, Synthetic; Vitiligo/etiology; mRNA Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vitiligo / Hypopigmentation / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Cosmet Dermatol Journal subject: Dermatology Year: 2022 Document Type: Article Affiliation country: Jocd.14843

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google